Nuritas
Nuritas is a Dublin-based biotech that uses its proprietary Magnifier AI platform to discover and clinically validate bioactive peptides from natural food sources, selling these ingredients B2B to consumer brands in supplements, functional foods, beverages, and cosmetics.
- Company typePrivate
- Founded2014
- HeadquartersDublin, Ireland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nuritas does
Nuritas Ltd is a Dublin-based biotechnology company founded in 2014 by Dr. Nora Khaldi that combines artificial intelligence with genomics to discover bioactive peptides in natural food sources such as fava beans and rice. Its core technology is Magnifier NπΦ, a proprietary AI platform purpose-built for peptide biology that screens billions of peptide sequences, predicts biological activity and bioavailability, and supports a six-step discovery process from AI-powered candidate screening through human clinical validation. The company has built the world's largest known library of natural peptides with identified functionalities, numbering over 8 million peptides, and has been issued 56 patents globally.
Nuritas commercializes four primary clinically validated peptide ingredients — PeptiStrong (muscle health), PeptiSleep (sleep quality), PeptiYouth (skin health), and PeptiProtect (topical protection) — alongside a research-stage antimicrobial peptide (PeptiSave). These ingredients are sold B2B, on a quote-based pricing model with multi-year contracts, to consumer brands and formulators that integrate them into functional foods, beverages, supplements, and cosmetics. As of 2025–2026, more than 100 commercial products globally contain Nuritas peptides, with over 200 million doses delivered across more than 31 countries. The company holds FDA GRAS status and Non-Novel Food designations in Canada and the EU, enabling cross-jurisdictional commercialization.
The business operates two GTM motions: direct enterprise field sales to major consumer goods companies (Nestlé, Mars, Givaudan, Sumitomo Corporation, BASF, L'Oréal) and an expanding network of regional distribution partners across Europe (Alifarma, Faravelli, Vivatis Pharma) supplemented by retail distribution in the United States via GNC, Vitamin Shoppe, and direct-to-consumer supplement brands. Revenue is derived from one-time/recurring ingredient sales plus custom peptide discovery partnerships structured as licensing/royalty arrangements. The company has raised approximately $87 million across multiple funding rounds, most recently a $42 million Series C in December 2024 led by M&G Investments and McWin Capital Partners, and is led by a team of scientists, AI specialists, and industry executives with a board and advisory bench that includes former PepsiCo CEO Indra Nooyi.
Nuritas firmographics
Firmographics- Name
- Nuritas
- Legal name
- Nuritas Ltd
- Website
- https://nuritas.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Nuritas is a Dublin-based biotech that uses its proprietary Magnifier AI platform to discover and clinically validate bioactive peptides from natural food sources, selling these ingredients B2B to consumer brands in supplements, functional foods, beverages, and cosmetics.
- Ownership category
- akta.pro rank
Nuritas industry classification
Industry- Product category
- Bioactive Peptide Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine) (AFAJAKAG)
- akta.pro secondary industries
- Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides) (AFAJAHAI), Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
Keywords
Where Nuritas is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Offices2 records
Markets served
Nuritas business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Peptide Ingredient Sales: Sale of proprietary bioactive peptide ingredients (PeptiStrong, PeptiSleep, PeptiYouth, PeptiProtect) to B2B companies for integration into functional foods, beverages, supplements, and cosmetics. Ingredients are sold directly to formulation, R&D, or procurement teams.
- Custom Peptide Discovery Partnerships: Custom peptide discovery powered by AI for specific health outcomes. Partner companies can access Nuritas's pipeline of intelligent ingredients in development and be first to access next generation ingredients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B ingredient sales - quote-based pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Nuritas product offering
Product offeringCore offering
Nuritas develops and sells clinically validated bioactive peptide ingredients (PeptiStrong®, PeptiSleep™, PeptiYouth™, PeptiProtect®) discovered through its proprietary Magnifier NπΦ™ AI platform. These plant-derived peptide ingredients are sold B2B to consumer-goods companies for formulation into functional foods, beverages, dietary supplements, and cosmetic products, supported by custom peptide discovery partnerships for major brands.
Product overview
Nuritas is a biotechnology company that developed a portfolio of clinically proven, AI-discovered peptide ingredients. The core offering consists of PeptiStrong® (muscle health), PeptiSleep™ (sleep quality), PeptiYouth™ (skin health), and PeptiProtect® (topical protection), all discovered and validated through the company's proprietary Magnifier NπΦ™ AI platform. The company operates as a B2B ingredient supplier, selling clinically validated peptide powders to consumer brands for integration into supplements, functional foods, beverages, and topical products. Over 100 consumer products now contain Nuritas SmartPeptides™, with commercial availability in more than 31 countries.
Differentiator
Problem solved
Functional benefit
Brands
- PeptiStrong: Plant-based peptide ingredient derived from fava beans for muscle health and performance, backed by clinical studies supporting strength, energy, and recovery.
- PeptiSleep
- PeptiYouth
- PeptiProtect
- Magnifier
Products and services
- PeptiStrong® Clinically studied plant-based bioactive peptide ingredient derived from fava beans that supports muscle strength, energy, and recovery. Sold B2B to consumer-goods, sports nutrition, and supplement brands (Cellucor, MuscleTech, Jacked Factory, Designs for Health, Nu Skin, GNC, Vitamin Shoppe) for formulation into functional foods, beverages, and supplements.
- PeptiSleep™ Plant-based bioactive peptide ingredient designed to support sleep quality and circadian rhythm, backed by clinical research. Sold B2B to consumer brands for incorporation into sleep-support supplements and functional beverages.
- PeptiYouth™ Plant-based bioactive peptide ingredient derived from rice proteins for skin health and beauty-from-within anti-aging applications. Validated through peer-reviewed research and sold B2B to cosmetics and supplement brands.
- PeptiProtect® Plant-based peptide ingredient for protective health benefits, used in oral and topical product formats. Sold B2B to consumer brands for protective functional applications.
- PeptiSave™ Antimicrobial peptide ingredient derived from peas, with demonstrated efficacy against foodborne pathogens including Escherichia coli O157:H7. Published in Frontiers in Microbiology and Food Science & Nutrition. Positioned as a research-stage antimicrobial peptide for food safety applications.
- Custom Peptide Discovery Partnerships B2B service offering where Nuritas applies its Magnifier AI platform to discover novel bioactive peptides tailored to a partner's specified health outcomes. Provides partners with early access to next-generation ingredients and exclusive pipeline opportunities. Customers include BASF Human Nutrition and other major CPG/ingredient companies.
Quantifiable outcome
- Discovery timeline reduced from 20-70 years to months
- +5 more outcomes
Companies that use Nuritas
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles3 records
Nuritas technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
Nuritas partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and major.
- MetaboTwin ConsortiumcoreFour-year TKI Agri & Food-funded research consortium led by Wageningen University & Research and Eindhoven University of Technology. Nuritas contributes food peptide ingredients for the world's first Human Dietary Digital Twin project studying metabolic responses to different protein sources.
- Liverpool John Moores UniversitycoreDouble-blinded RCT partnership examining PeptiStrong's ability to support healthy aging in adults aged 60-85, in collaboration with StudySetGo. Results expected Q3 2026.
- AlifarmamajorEuropean distribution partner for Spain and Portugal markets.
- FaravellimajorEuropean distribution partner for Italy market.
- Vivatis PharmamajorEuropean distribution partner for Poland, Czech Republic, Slovakia, and the three Baltic markets.
- NestlécoreMajor consumer goods company partnership for ingredient development and product integration.
- MarscoreMajor consumer goods company partnership for ingredient development and product integration.
- GivaudancoreLeading flavor and fragrance company partnership for ingredient innovation and product applications.
- Sumitomo CorporationmajorJapanese trading company partnership for ingredient distribution and market expansion.
- BASFmajorPartnership collaboration with BASF Human Nutrition. Vice President Tina Low quoted on consumer demand for plant-based solutions for sports-related inflammation.
Scale indicators8 records
Recent moves8 records
Expansion highlights8 records
Nuritas competitors and assessment
Company assessmentEmerging players
- Phytolon: Phytolon uses precision fermentation to produce natural food colors from plants, an emerging player in AI/biotech-enabled food ingredients with similar go-to-market into CPG.
- Amai Proteins: Amai uses computational protein design and AI to create sweet-protein and functional food proteins, an emerging peer that overlaps with Nuritas' AI-driven bioactive ingredient pipeline.
- MycoTechnology: MycoTechnology uses fermentation platforms to develop plant-based functional food ingredients, an adjacent emerging player in the CPG ingredient space where Nuritas competes.
Direct peers
- Brightseed: Brightseed uses AI to discover bioactive compounds in plants for food, beverage, and supplement applications, closely mirroring Nuritas' AI-discovered bioactive peptide model and B2B ingredient commercialization approach.
- Shiru: Shiru applies AI to discover and design novel food proteins and ingredients, comparable to Nuritas' Magnifier-driven peptide discovery and B2B ingredient supply into CPG.
- Geltor: Geltor produces animal-free functional proteins (including collagen-equivalent peptides) via precision fermentation, competing with Nuritas in the bioactive protein/peptide ingredient space for beauty and nutrition applications.
Broad incumbents
- ADM (Health & Wellness / Biopolis): ADM is a global CPG ingredient powerhouse with a fast-growing Health & Wellness and microbiome/probiotic portfolio, representing a broad incumbent competitor in the branded functional-ingredient space.
- Kerry Group: Kerry is a global taste and nutrition ingredient supplier serving the same CPG and supplement customers as Nuritas, with broader portfolios across functional foods and beverages.
- IFF (Health & Biosciences): International Flavors & Fragrances has a large Health & Biosciences division producing bioactive ingredients (including proteins, enzymes, and cultures) for food, beverage, and supplement customers, overlapping with Nuritas' customer set.
- BASF Human Nutrition: BASF is a global nutrition ingredient supplier and an existing Nuritas partner; it competes in the broader bioactive and plant-based ingredient market that Nuritas addresses.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Nuritas social profiles
Digital presenceNuritas compliance and trust
Trust signalCompliance2 records
Nuritas financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nuritas leadership team
Management profileNumber of profiles
Profiles13 records
Nuritas funding detail
Funding detailFunding overview
Funding rounds9 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nuritas M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nuritas
What does Nuritas do?
Nuritas develops and sells clinically validated bioactive peptide ingredients (PeptiStrong®, PeptiSleep™, PeptiYouth™, PeptiProtect®) discovered through its proprietary Magnifier NπΦ™ AI platform. These plant-derived peptide ingredients are sold B2B to consumer-goods companies for formulation into functional foods, beverages, dietary supplements, and cosmetic products, supported by custom peptide discovery partnerships for major brands.
Is Nuritas a public or private company?
Nuritas is a private company. It is classified as venture growth investor backed and is currently operating.
When was Nuritas founded?
Nuritas was founded in 2014. It employs 11 to 50 people.
Where is Nuritas based?
Nuritas is headquartered in Dublin, Ireland, in the Europe region.
How does Nuritas make money?
Two revenue lines are on record. Peptide Ingredient Sales are the primary driver. The others are custom Peptide Discovery Partnerships.
Who are Nuritas's main competitors?
Emerging players on record are Phytolon, Amai Proteins and MycoTechnology. Direct peers are Brightseed, Shiru and Geltor. Broad incumbents are ADM (Health & Wellness / Biopolis), Kerry Group, IFF (Health & Biosciences) and BASF Human Nutrition.
Does Nuritas have an API?
No public API is recorded for Nuritas.
What industry is Nuritas in?
Nuritas's product category is Bioactive Peptide Ingredients. Its primary akta.pro industry code is AFAJAKAG, Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine), with a secondary code of AFAJAHAI, Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides). Its NAICS code is 325411 and its SIC code is 2833.